Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
about
Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosisDiscovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseStructure-Guided Discovery of Phenyl-diketo Acids as Potent Inhibitors of M. tuberculosis Malate SynthaseTHPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteriaIdentification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrBTetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infectionIdentification of KasA as the cellular target of an anti-tubercular scaffoldDiscovery of Q203, a potent clinical candidate for the treatment of tuberculosis.Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic.A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.Lansoprazole is an antituberculous prodrug targeting cytochrome bc1.Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis.Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections.Testing tuberculosis drug efficacy in a zebrafish high-throughput translational medicine screenMycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.A Focused Screen Identifies Antifolates with Activity on Mycobacterium tuberculosis.Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of CaseumAntitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor.Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase.A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence.The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model.Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface.Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
P2860
Q27306024-97FBDB7B-4A4B-42D6-95B9-E52810DFA156Q27644677-828FE304-F3E9-4694-B10D-15C87BB11CE7Q27675581-B1247630-98DB-442C-8C4C-E1C60CD3723EQ27727961-BEE4AB5F-B817-40A7-87F6-65870FBE1B59Q28484670-8A25AF67-8903-4732-9DEF-8F353597C400Q28486239-1043FBA1-7B93-4FEC-9688-D5F386036963Q28486312-CE7A7999-3983-4649-A536-ED062BEACE9DQ28830072-019F6E10-15BB-4E9C-98AF-961CA448E5ACQ30352594-452914B6-EB12-41AA-BAE2-0C7A0C61A2BCQ30620897-8E1EBFCC-B49C-4C07-9A4B-673962C3ADE7Q34283632-BDF0B2ED-D81C-4F6D-AB35-F9374BF4E67CQ34484243-08C60CFD-8440-49D9-BC74-169F747945C2Q34544301-33B4EFBE-8C91-44DA-A562-A45BC6D81903Q34737143-A9D88D5F-55DD-4FE1-BA6E-07D3E9B5B2C5Q34737913-32FB2E78-31BC-496D-ADA5-42D624291857Q35076966-495BCC0A-8411-4F9F-AE3C-2368CCC23FC1Q35106008-B3716043-F6C1-4617-A9EB-C0D825427153Q35169124-93526E7B-6B47-43A2-84A4-8BBF5D6F1BBEQ35894966-752C573E-BD33-4839-A35A-2AF87D13001FQ36571981-D6EDD88C-21C3-4E88-95F2-6C78F3ECEB41Q37034701-971D027C-9ADE-4877-B6C1-F62BCBFFA399Q37095473-EF894A06-B1E5-43D5-96F9-BAD4DB4C7CFCQ37340936-4B6F3F6A-9103-40A1-A043-BC99567B4B08Q37733488-63DC3E9C-302C-42ED-876B-D585D6D2EB5FQ38637128-2ED10E43-CEC4-407F-AD96-2A3B8513E1CFQ58759751-9CD0F2DA-8A97-4232-B387-28A4F14BF7A2
P2860
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
@ast
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
@en
type
label
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
@ast
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
@en
prefLabel
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
@ast
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
@en
P2093
P2860
P356
P1476
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
@en
P2093
Iñigo Angulo-Barturen
Joaquín Rullas
José Francisco García-Bustos
Juan Ignacio García
Manuela Beltrán
Neus Cáceres
Pere-Joan Cardona
P2860
P304
P356
10.1128/AAC.01423-09
P407
P577
2010-02-16T00:00:00Z